Topical Treatment of Ulcerative Colitis using Enemas Containing 5-Aminosalicylic Acid and Beclomethasone Dipropionate
5-Aminosalicylic acid (5-ASA) enemas constitute a first-line therapy for patients with mild to moderate attacks of ulcerative colitis. To date, based on the results of different studies, 5-ASA enemas appear to be satisfactory in at least two-thirds of patients treated. Beclomethasone is one of the n...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
1990-01-01
|
| Series: | Canadian Journal of Gastroenterology |
| Online Access: | http://dx.doi.org/10.1155/1990/164896 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832567932643704832 |
|---|---|
| author | M Campieri P Gionchetti A Belluzzi M Tampieri C Brignola M Ferretti M Miglioli L Barbara |
| author_facet | M Campieri P Gionchetti A Belluzzi M Tampieri C Brignola M Ferretti M Miglioli L Barbara |
| author_sort | M Campieri |
| collection | DOAJ |
| description | 5-Aminosalicylic acid (5-ASA) enemas constitute a first-line
therapy for patients with mild to moderate attacks of ulcerative colitis. To date,
based on the results of different studies, 5-ASA enemas appear to be satisfactory
in at least two-thirds of patients treated. Beclomethasone is one of the new
corticosteroids which appear to have minimal systemic effects. The authors have
assessed the efficacy of a four week course of 3 mg beclomethasone enemas
compared to 2 g 5-ASA enemas in patients with ulcerative colitis. Preliminary
analysis would suggest that both therapies are effective in more than 50% of cases. |
| format | Article |
| id | doaj-art-45829b1eae354e6d8089e7a1028be993 |
| institution | Kabale University |
| issn | 0835-7900 |
| language | English |
| publishDate | 1990-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Canadian Journal of Gastroenterology |
| spelling | doaj-art-45829b1eae354e6d8089e7a1028be9932025-02-03T01:00:04ZengWileyCanadian Journal of Gastroenterology0835-79001990-01-014748148310.1155/1990/164896Topical Treatment of Ulcerative Colitis using Enemas Containing 5-Aminosalicylic Acid and Beclomethasone DipropionateM CampieriP GionchettiA BelluzziM TampieriC BrignolaM FerrettiM MiglioliL Barbara5-Aminosalicylic acid (5-ASA) enemas constitute a first-line therapy for patients with mild to moderate attacks of ulcerative colitis. To date, based on the results of different studies, 5-ASA enemas appear to be satisfactory in at least two-thirds of patients treated. Beclomethasone is one of the new corticosteroids which appear to have minimal systemic effects. The authors have assessed the efficacy of a four week course of 3 mg beclomethasone enemas compared to 2 g 5-ASA enemas in patients with ulcerative colitis. Preliminary analysis would suggest that both therapies are effective in more than 50% of cases.http://dx.doi.org/10.1155/1990/164896 |
| spellingShingle | M Campieri P Gionchetti A Belluzzi M Tampieri C Brignola M Ferretti M Miglioli L Barbara Topical Treatment of Ulcerative Colitis using Enemas Containing 5-Aminosalicylic Acid and Beclomethasone Dipropionate Canadian Journal of Gastroenterology |
| title | Topical Treatment of Ulcerative Colitis using Enemas Containing 5-Aminosalicylic Acid and Beclomethasone Dipropionate |
| title_full | Topical Treatment of Ulcerative Colitis using Enemas Containing 5-Aminosalicylic Acid and Beclomethasone Dipropionate |
| title_fullStr | Topical Treatment of Ulcerative Colitis using Enemas Containing 5-Aminosalicylic Acid and Beclomethasone Dipropionate |
| title_full_unstemmed | Topical Treatment of Ulcerative Colitis using Enemas Containing 5-Aminosalicylic Acid and Beclomethasone Dipropionate |
| title_short | Topical Treatment of Ulcerative Colitis using Enemas Containing 5-Aminosalicylic Acid and Beclomethasone Dipropionate |
| title_sort | topical treatment of ulcerative colitis using enemas containing 5 aminosalicylic acid and beclomethasone dipropionate |
| url | http://dx.doi.org/10.1155/1990/164896 |
| work_keys_str_mv | AT mcampieri topicaltreatmentofulcerativecolitisusingenemascontaining5aminosalicylicacidandbeclomethasonedipropionate AT pgionchetti topicaltreatmentofulcerativecolitisusingenemascontaining5aminosalicylicacidandbeclomethasonedipropionate AT abelluzzi topicaltreatmentofulcerativecolitisusingenemascontaining5aminosalicylicacidandbeclomethasonedipropionate AT mtampieri topicaltreatmentofulcerativecolitisusingenemascontaining5aminosalicylicacidandbeclomethasonedipropionate AT cbrignola topicaltreatmentofulcerativecolitisusingenemascontaining5aminosalicylicacidandbeclomethasonedipropionate AT mferretti topicaltreatmentofulcerativecolitisusingenemascontaining5aminosalicylicacidandbeclomethasonedipropionate AT mmiglioli topicaltreatmentofulcerativecolitisusingenemascontaining5aminosalicylicacidandbeclomethasonedipropionate AT lbarbara topicaltreatmentofulcerativecolitisusingenemascontaining5aminosalicylicacidandbeclomethasonedipropionate |